Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.

Optimal therapeutic strategies for serious infections caused by borderline and heterotypic oxacillin-resistant Staphylococcus aureus (BORSA and ORSA) strains have not been fully characterized. Recent evidence suggests that the dominant penicillin-binding protein of ORSA strains (PBP 2a) shows good a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Hirano, L, Bayer, A S
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1991
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245079/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2069374/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.4.685
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki